- Deciphera Pharmaceuticals, Inc. to Present at the SVB Leerink 10th Annual Global Healthcare Conference
- Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2020 Financial Results
- Deciphera Pharmaceuticals, Inc. to Present at the Guggenheim Healthcare Talks 2021 Idea Forum Oncology Day
- Deciphera Pharmaceuticals to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call and Webcast on February 9, 2021
- Deciphera Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Corporate Milestones
- Deciphera Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference
- Deciphera Pharmaceuticals Completes Target Enrollment in the INTRIGUE Phase 3 Clinical Study of QINLOCK® (Ripretinib) in Patients with Second-Line Gastrointestinal Stromal Tumor
Deciphera Pharmaceuticals Inc (DCPH:NSQ) closed at 43.78, 32.27% above the 52 week low of 33.10 set on Mar 16, 2020.
33.10Mar 16 202068.40Nov 16 2020
Markit short selling activity
|Market cap||2.45bn USD|
|EPS (TTM)||-4.79 |
Data delayed at least 15 minutes, as of Feb 26 2021 21:00 GMT.